MOTS-c Dosage Guide: Complete Charts, Protocols & Timing

Evidence-based MOTS-c dosage guide covering daily protocols, subcutaneous injection charts, weight loss dosing, cycling schedules, timing recommendations, and stacking considerations for the mitochondrial peptide gaining rapid popularity in 2026.

MOTS-c Dosage Chart: Quick Reference

The following chart summarizes the most widely used MOTS-c dosing protocols based on available research and clinical practitioner guidance. MOTS-c is a mitochondrial-derived peptide that activates AMPK pathways to improve metabolic health, insulin sensitivity, and fat oxidation. Dosing is not yet standardized through large clinical trials, so these protocols represent current best practices from the peptide therapy community.

All doses are administered via subcutaneous injection. Optimal human dosing has not been established through Phase 3 clinical trials. Work with a qualified peptide therapy provider to determine the best protocol for your individual needs.

Understanding MOTS-c Dosing Fundamentals

MOTS-c dosing differs from many other peptides in several important ways. First, MOTS-c is an endogenous mitochondrial peptide your body naturally produces, meaning exogenous administration supplements an existing biological pathway rather than introducing a foreign compound. Second, its primary mechanism—AMPK activation—produces cumulative rather than acute effects, so consistent dosing over weeks matters more than any single dose.

The research-derived dosing range for MOTS-c in humans translates to approximately 5-15 mg per day administered subcutaneously. Animal studies used weight-based dosing (typically 5-15 mg/kg in mice), but direct translation to human dosing uses allometric scaling rather than simple weight conversion. The resulting human-equivalent doses of 5-15 mg daily represent the range most commonly employed by practitioners and researchers.

Unlike GLP-1 medications that require careful dose titration to manage gastrointestinal side effects, MOTS-c is generally well-tolerated from the start. Most users can begin at 5 mg daily without significant adverse effects, making the titration period more about optimizing metabolic response than managing tolerability.

MOTS-c Dosage Per Day: Detailed Breakdown

The daily dose you choose depends on your goals, experience level, and how your body responds during the initial weeks. Here is a detailed breakdown of each dosing tier.

5 mg per day (beginner/conservative): This dose provides meaningful AMPK activation while minimizing any potential side effects. Research shows detectable metabolic changes at this level, including improved fasting glucose and enhanced fat oxidation markers. Ideal for first-time peptide users, individuals over 60, or those using MOTS-c as part of a multi-peptide stack where cumulative effects matter.

10 mg per day (standard): The most widely used dose, representing the sweet spot between efficacy and cost. At 10 mg daily, users typically report noticeable improvements in energy, exercise performance, and body composition within 3-4 weeks. This dose produces robust AMPK activation sufficient for metabolic health improvement, insulin sensitization, and meaningful fat loss when combined with exercise.

15 mg per day (advanced): Reserved for experienced users actively pursuing aggressive fat loss or metabolic optimization goals. Higher doses increase AMPK activation further but with diminishing returns. Some practitioners recommend splitting this dose (7.5 mg morning + 7.5 mg pre-workout) to maintain more consistent blood levels throughout the day. Monitor for hypoglycemia if combining with fasting protocols.

Weekly Dosing Schedules and Frequency

While daily dosing provides maximum metabolic benefit, several weekly schedules accommodate different preferences and goals.

Daily (7 days/week): The gold standard for metabolic health and weight loss. Consistent daily AMPK activation produces the strongest cumulative effects on insulin sensitivity, mitochondrial biogenesis, and fat oxidation. Recommended for 8-12 week focused protocols.

5 on / 2 off: A practical alternative that maintains approximately 85-90% of daily dosing benefits while reducing injection frequency. Typically Monday through Friday with weekends off. Popular among users who prefer a structured schedule aligned with their work week.

3-4 times per week (intermittent): Best suited for maintenance phases after an initial daily loading period, or for users combining MOTS-c with other metabolic interventions. Spread doses evenly (e.g., Monday/Wednesday/Friday or Monday/Wednesday/Friday/Sunday). While less potent than daily dosing, intermittent protocols still provide meaningful metabolic support at lower cost.

Regardless of weekly schedule, maintain consistent timing on injection days. MOTS-c has a half-life of several hours, so daily dosing provides more stable metabolic activation than intermittent approaches.

Best Time to Take MOTS-c: Timing Optimization

When you take MOTS-c matters for optimizing its metabolic effects. AMPK activation has circadian interactions that influence when dosing produces the best results.

Morning (recommended): Administering MOTS-c 30-60 minutes before breakfast aligns AMPK activation with your body's natural morning metabolic upswing. Morning dosing maximizes fat oxidation during the first half of the day when cortisol and metabolic rate are naturally elevated. If you practice intermittent fasting, morning MOTS-c extends the fasted-state metabolic benefits.

Pre-workout (30-45 minutes before exercise): MOTS-c enhances exercise performance through improved mitochondrial efficiency and fat oxidation. Pre-workout dosing may amplify training adaptations—especially for endurance and metabolic conditioning workouts. If you train in the morning, a single morning dose serves both purposes.

Split dosing (morning + pre-workout): For doses above 10 mg daily, splitting into two administrations (e.g., 5 mg morning + 5 mg pre-workout) maintains more consistent AMPK activation. This approach is particularly effective for users training in the afternoon or evening.

Evening (less ideal): AMPK activation can interfere with mTOR signaling important for recovery during sleep. Some users report mild insomnia or restlessness with evening dosing. If evening is your only option, dose at least 3-4 hours before bedtime.

MOTS-c Dosage for Weight Loss

MOTS-c supports weight loss primarily through AMPK-mediated fat oxidation enhancement rather than appetite suppression. This distinguishes it from semaglutide and other weight loss peptides that reduce hunger as their primary mechanism.

The optimal weight loss protocol uses 10 mg daily, administered in the morning before fasted cardio or first meal. Combined with a moderate caloric deficit (300-500 calories below maintenance) and regular exercise (both cardio and resistance training), users typically see improved body composition within 4-6 weeks. The fat loss effect accelerates as mitochondrial adaptations compound over the 8-12 week protocol.

For enhanced results, some practitioners recommend pairing MOTS-c with complementary fat-loss peptides. A popular combination includes MOTS-c (10 mg morning) with AOD-9604 (300 mcg) for direct lipolysis support, though this adds complexity and cost. Others combine MOTS-c with GH secretagogues for synergistic metabolic effects.

Important: MOTS-c is not a substitute for GLP-1 medications in individuals with obesity or metabolic syndrome requiring significant weight loss. For those needing 15%+ body weight reduction, FDA-approved options like semaglutide or tirzepatide offer stronger evidence and larger effect sizes.

Cycling Protocols: On and Off Periods

Cycling MOTS-c—alternating periods of use with periods off—is standard practice for most users. While MOTS-c is an endogenous peptide (your body makes it naturally), supplementing at pharmacological doses warrants periodic breaks.

Standard cycle (8 weeks on / 4 weeks off): The most conservative and commonly recommended approach. Eight weeks provides sufficient time for meaningful metabolic adaptations. The four-week break allows assessment of retained benefits and prevents potential receptor adaptation.

Extended cycle (12 weeks on / 4 weeks off): Suitable for users with specific metabolic goals (e.g., insulin sensitization, body composition improvement) who tolerate 8 weeks well. The additional four weeks allows deeper metabolic adaptations to develop fully.

Long-term maintenance (16 weeks on / 4-6 weeks off): For users focusing on longevity and anti-aging who want maximum mitochondrial support. This extended protocol requires monitoring of metabolic markers (fasting glucose, insulin, lipids) to ensure continued benefit.

During off-cycle periods, mitochondrial adaptations partially persist. Users often retain improved insulin sensitivity and exercise capacity for 2-4 weeks after discontinuation. Maintaining exercise and nutrition habits during off-cycles preserves gains most effectively.

Reconstitution and Injection Preparation

MOTS-c is supplied as a lyophilized powder requiring reconstitution before injection. Proper preparation ensures accurate dosing and peptide stability. For a detailed walkthrough, see our peptide reconstitution guide and reconstitution calculator.

Standard reconstitution example: A 10 mg vial reconstituted with 1 mL of bacteriostatic water yields a concentration of 10 mg/mL. At this concentration, a 5 mg dose equals 0.5 mL (50 units on an insulin syringe) and a 10 mg dose equals 1.0 mL (100 units). Adjust water volume based on your preferred concentration.

Injection technique: Administer subcutaneously into the abdominal fat pad, outer thigh, or upper arm. Use a 29-31 gauge insulin syringe. Rotate injection sites to prevent lipodystrophy. Pinch skin, insert needle at a 45-degree angle, inject slowly, and hold for 5-10 seconds before withdrawing. See our complete injection guide for detailed technique.

Storage: Store reconstituted MOTS-c refrigerated (2-8 degrees C) and use within 28-30 days. Unreconstituted vials can be stored frozen for longer shelf life or refrigerated for several months. See our peptide storage guide for complete storage recommendations.

MOTS-c Stacking Dosage Considerations

When combining MOTS-c with other peptides, maintain the standard MOTS-c dose (5-10 mg daily) while following individual dosing guidelines for companion peptides. MOTS-c operates through AMPK pathways that complement rather than compete with most other peptide mechanisms.

MOTS-c + BPC-157: A recovery-focused stack combining metabolic optimization with tissue repair. Use MOTS-c at 5-10 mg morning and BPC-157 at 250-500 mcg twice daily. The combination supports both metabolic conditioning and injury recovery for active individuals.

MOTS-c + SS-31: The comprehensive mitochondrial stack. MOTS-c activates AMPK for metabolic optimization while SS-31 stabilizes cardiolipin for direct mitochondrial membrane support. These complementary mechanisms target different aspects of mitochondrial health for synergistic anti-aging benefit.

MOTS-c + CJC-1295/Ipamorelin: Combines metabolic efficiency with growth hormone release. Use MOTS-c morning and GH secretagogues at bedtime per standard CJC-1295/Ipamorelin dosing. Timing separation ensures AMPK and mTOR pathway activation occur at different times, avoiding potential interference.

MOTS-c + NAD+ support: Both target longevity pathways through complementary mechanisms. MOTS-c increases NAD+ indirectly through AMPK activation; NAD+ injections or precursors provide direct NAD+ substrate. The combination may offer more comprehensive cellular energy optimization than either alone.

Monitoring Progress and Adjusting Dose

Tracking objective markers helps optimize your MOTS-c protocol and determine whether dose adjustments are needed.

Baseline labs (before starting): Fasting glucose, fasting insulin, HbA1c, lipid panel (triglycerides, HDL, LDL), and body composition (DEXA scan if available). These establish your metabolic starting point for comparison.

4-week check: Repeat fasting glucose and insulin. Most users see initial improvements by this point. If no metabolic changes are evident, consider increasing from 5 mg to 10 mg daily. Subjective markers (energy, exercise performance, recovery) should also show early improvement.

8-week assessment: Full lab panel repeat including lipids and body composition. This timepoint typically shows the most significant improvements. Triglycerides often decrease 20-40%, and fasting insulin levels improve noticeably. Adjust cycling and future dosing based on these results.

If you experience side effects at any point (persistent nausea, injection site reactions, hypoglycemia symptoms), reduce the dose by 50% for one week before gradually re-titrating. Individuals taking diabetes medications should coordinate MOTS-c dosing closely with their healthcare provider as insulin sensitivity improvements may necessitate medication dose reductions.

Safety Considerations and Contraindications

MOTS-c has a favorable safety profile based on available data, but several important considerations apply to dosing decisions.

The peptide is endogenously produced by your mitochondria, suggesting inherent biological compatibility. However, supplemental doses exceed natural production levels, so extrapolating safety from endogenous function requires caution. Long-term human safety data at pharmacological doses remains limited.

Individuals with diabetes or prediabetes using glucose-lowering medications should begin at the lowest dose (5 mg daily) and monitor blood glucose closely. MOTS-c improves insulin sensitivity, which combined with medication may cause hypoglycemia. Dose adjustments to existing medications may be needed under medical supervision.

Pregnant or breastfeeding individuals should avoid MOTS-c, as safety in these populations has not been studied. Those with active cancer should consult their oncologist before use, as AMPK activation has complex effects on cell growth pathways. For general peptide safety information and sourcing guidance, see our buying peptides safely guide.

Frequently Asked Questions